Skip to main content
OSTI.GOVU.S. Department of Energy Office of Scientific and Technical Information
U.S. Department of Energy
Office of Scientific and Technical Information
 

Thyroglobulin levels to follow-up patients with treated differentiated thyroid carcinoma

Journal Article · · Cancer Detect. Prev.; (United States)
OSTI ID:6879818
; ; ; ; ;
Serum thyroglobulin (hTg) measurements by commercial radioimmunoassay were performed in the follow-up of 118 patients with differentiated thyroid carcinoma undergoing I-131 local and whole-body scans following surgery and I-131 therapy. Patients with positive anti-hTg antibodies (23% of cases) were excluded. In all remaining I-131 accumulating residual, recurrent, or metastatic tumors, hTg levels were elevated (greater than 6.25 ng/ml, minimum detectable value). Twelve patients with neither recurrence nor metastases had elevate hTg levels. Sensitivity and specificity depended on the threshold used for elevate hTg levels. At an hTg-threshold of 6.25 ng/ml sensitivity has 100%, specificity has 82%. As hTg levels were reported to depend on endogenous TSH stimulation, it is not yet advisable to replace I-131 scans totally by hTg determination. After having determined an hTg ''baseline'' below detectable values (less than 6.25 ng/ml), we reduced the number of I-131 scans by half. However, elevated hTg levels were an indication for an I-131 scan. Therefore, on the basis of 23% of our patients who had anti-hTg antibodies the need exists to develop a commercial assay which is independent from antibodies.
Research Organization:
Department of Nuclear Medicine, Klinikum Grosshadern, University of Munich, Federal Republic of Germany
OSTI ID:
6879818
Journal Information:
Cancer Detect. Prev.; (United States), Journal Name: Cancer Detect. Prev.; (United States) Vol. 7:2; ISSN CDPRD
Country of Publication:
United States
Language:
English

Similar Records

Critical evaluation of serum thyroglobulin levels and I-131 scans in post-therapy patients with differentiated thyroid carcinoma: concise communication
Journal Article · Sun Feb 28 23:00:00 EST 1982 · J. Nucl. Med.; (United States) · OSTI ID:5176664
Usefulness of thallium-201 imaging in the diagnosis of metastases from differentiated thyroid carcinoma
Conference · Sat Dec 31 23:00:00 EST 1983 · J. Nucl. Med.; (United States) · OSTI ID:6844556
Sequential serum thyroglobulin determinations, /sup 131/I scans, and /sup 131/I uptakes after triiodothyronine withdrawal in patients with thyroid cancer
Journal Article · Mon Nov 30 23:00:00 EST 1981 · J. Clin. Endocrinol. Metab.; (United States) · OSTI ID:5639312

Related Subjects

550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BLOOD CHEMISTRY
BODY
CARCINOMAS
DAYS LIVING RADIOISOTOPES
DISEASES
ENDOCRINE GLANDS
GLANDS
GLOBULINS
INTERMEDIATE MASS NUCLEI
IODINE 131
IODINE ISOTOPES
ISOTOPE APPLICATIONS
ISOTOPES
MEDICINE
METASTASES
NEOPLASMS
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANS
PATIENTS
PROTEINS
RADIOASSAY
RADIOIMMUNOASSAY
RADIOISOTOPES
SURGERY
THYROGLOBULIN
THYROID
TRACER TECHNIQUES